SPALLA, MELISSA
 Distribuzione geografica
Continente #
NA - Nord America 4.846
AS - Asia 2.875
EU - Europa 2.785
SA - Sud America 342
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 64
OC - Oceania 9
AN - Antartide 1
Totale 11.013
Nazione #
US - Stati Uniti d'America 4.663
CN - Cina 1.532
SG - Singapore 624
IE - Irlanda 538
IT - Italia 402
UA - Ucraina 382
DE - Germania 320
FI - Finlandia 262
BR - Brasile 254
RU - Federazione Russa 236
HK - Hong Kong 231
FR - Francia 196
VN - Vietnam 195
GB - Regno Unito 179
SE - Svezia 120
CA - Canada 107
IN - India 62
BD - Bangladesh 45
ZA - Sudafrica 31
NL - Olanda 27
BE - Belgio 26
JP - Giappone 25
MX - Messico 24
IQ - Iraq 22
JO - Giordania 22
AR - Argentina 20
PL - Polonia 20
CO - Colombia 17
ES - Italia 17
VE - Venezuela 16
CZ - Repubblica Ceca 14
TR - Turchia 14
EC - Ecuador 13
MA - Marocco 11
PK - Pakistan 11
IR - Iran 10
KE - Kenya 9
AU - Australia 8
CR - Costa Rica 8
HU - Ungheria 8
IL - Israele 8
JM - Giamaica 8
MY - Malesia 8
PH - Filippine 8
SA - Arabia Saudita 8
EG - Egitto 7
LT - Lituania 7
NI - Nicaragua 7
TN - Tunisia 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
ID - Indonesia 6
PE - Perù 6
SV - El Salvador 6
TH - Thailandia 6
BO - Bolivia 5
CL - Cile 5
DZ - Algeria 5
GT - Guatemala 5
NG - Nigeria 5
PR - Porto Rico 5
CW - ???statistics.table.value.countryCode.CW??? 4
ET - Etiopia 4
EU - Europa 4
KR - Corea 4
MU - Mauritius 4
UY - Uruguay 4
AO - Angola 3
AT - Austria 3
BB - Barbados 3
CH - Svizzera 3
KZ - Kazakistan 3
LB - Libano 3
RO - Romania 3
TT - Trinidad e Tobago 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
LV - Lettonia 2
NP - Nepal 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GP - Guadalupe 1
Totale 10.944
Città #
Chandler 606
Ashburn 592
Dublin 536
Jacksonville 457
San Jose 365
Singapore 356
Nanjing 316
Beijing 281
Dallas 276
Hong Kong 226
Council Bluffs 165
Boardman 163
Los Angeles 130
Nanchang 126
Ann Arbor 105
Wilmington 104
Changsha 95
Shenyang 94
Lawrence 93
Princeton 93
Medford 91
Hebei 88
Lauterbourg 82
Helsinki 78
Ho Chi Minh City 69
Munich 63
Jiaxing 61
Tianjin 61
Milan 56
Shanghai 51
Toronto 50
Hanoi 49
Hangzhou 48
Moscow 43
Washington 40
Buffalo 38
New York 34
Pavia 34
Woodbridge 30
Santa Clara 29
Verona 28
Falkenstein 27
Brussels 25
Johannesburg 25
São Paulo 25
Tokyo 24
Amman 21
Frankfurt am Main 21
Orem 21
Redondo Beach 20
Chennai 17
Montreal 16
Norwalk 16
San Francisco 16
Kunming 15
London 15
Warsaw 15
Atlanta 14
Auburn Hills 14
Chicago 14
Des Moines 14
Jinan 14
Amsterdam 13
Brooklyn 13
Rome 13
Denver 12
Falls Church 12
Seattle 12
Poplar 11
Redwood City 11
Haiphong 10
Manchester 10
Florence 9
Guangzhou 9
Nairobi 9
Ottawa 9
Pune 9
Baghdad 8
Caracas 8
Houston 8
Phoenix 8
Turku 8
Zhengzhou 8
Bogotá 7
Brasília 7
Da Nang 7
Las Vegas 7
Managua 7
Ningbo 7
Rio de Janeiro 7
Ankara 6
Lanzhou 6
Morgex 6
Querétaro 6
Quito 6
San José 6
Tashkent 6
Turin 6
Boston 5
Charlotte 5
Totale 7.008
Nome #
Co-presenza di Acinetobacter baumannii e Klebsiella pneumoniae produttori di carbapenemasi di tipo OXA e KPC in pazienti ospedalizzati con infezioni gravi 183
A Travel-Related Case of NDM-5-Producing Escherichia coli in Northern Italy 182
Diffusione clonale di E. coli kpc-produttori in una struttura di lungodegenza del nord Italia 177
Emergenza di isolati clinici di Acinetobacter baumannii OXA-23 produttori in un ospedale del nord Italia. 175
Prevalenza di beta-lattamasi di tipo CTX-M in isolati di Escherichia coli in un ospedale del nord Italia 162
Caratteristiche di antibiotico-resistenza in stipiti di Enterobatteri isolati da urinocolture di pazienti comunitari della provincia di Pavia 161
Resistenza mediata da metallo-Beta-lattamasi in P. aeruginosa in una struttura riabilitativa 160
Klebsiella oxytoca e Citrobacter koseri ESbL- e VIM-produttori in un paziente in riabilitazione cardiologica: caso clinico 160
CARATTERIZZAZIONE DI ENTEROBATTERI VIM PRODUTTORI ISOLATI IN QUATTRO OSPEDALI ITALIANI 160
Assessment of a rapid molecular method for the identification of Mycobacterium tuberculosis 159
Caratterizzazione molecolare delle ESbL prodotte da ceppi uropatogeni comunitari di Escherichia coli. 156
Valutazione del sistema BD ProbeTec ET per la diagnosi rapida di Mycobacterium tuberculosis complex 155
Sensibilità in vitro al fluconazolo di isolati vaginali di Candida spp. 154
Emergence of KPC-type producing Escherichia coli ST131 from three acute care hospitals and two long term and rehabilitation facilities in northern Italy 154
Antibiotic Resistance inEnterobacteriaceae UTI’s Isolates: An Update from the Northern Italy Community 152
Gentamicin Sulfate PEG-PLGA/PLGA-H Nanoparticles: Screening Design and Antimicrobial Effect Evaluation toward Clinic Bacterial Isolates 149
Detection of ESBL-producing Gram-negative bacteria from surface and ground-waters in the Po Valley 146
Evaluation of the LIPA assay in clinical Mycobacterium tuberculosis specimens 144
Biofilm formation and aggregative adherence of beta-lactamase producing Proteus mirabilis clinical isolates in Italy 141
Dissemination of a CMY-16 producing clone of P. mirabilis in long-term care and rehabilitation facilities of northern Italy 140
Detection of CTX-M-14 B-lactamase in Escherichia coli from a long-term care and rehabilitation facility in northern Italy 138
Detection of an IncA/C plasmid encoding VIM-4 and CMY-4 β-lactamases in Klebsiella oxytoca and Citrobacter koseri from an inpatient in a cardiac rehabilitation unit 135
EVALUATION OF HIV-RELATED ACIDS AND PAPILLOMAVIRUS DNA IN CERVICOVAGINAL SECRETIONS OF HIV-POSITIVE WOMEN. 133
Correlation between human immunodeficiencyvirus type 1 levels and cytokine profile into thecervicovaginal secretions of a female cohort 132
Acquired Metallo-β-Lactamases in Pseudomonas aeruginosa: Results of the First Italian Nationwide Survey. 131
Acquired AmpC type beta-lactamases: an emerging problem in Italian long-term care and rehabilitation facilities 131
Multifocal spreading of an OXA-23-producing Acinetobacter baumannii clone in different italian clinical settings 130
OXA-244-Producing ST131 Escherichia coli From Surface and Groundwaters of Pavia Urban Area (Po Plain, Northern Italy) 130
Detection of CTX-M beta-lactamases in Escherichia coli strains from a hospital of Northern Italy 129
Detection of an IncA/C plasmid encoding VIM-4 and CMY-4 β-lactamases in Klebsiella oxytoca and Citrobacter koseri from an inpatient at Cardiological Rehabilitation ward 126
Nosocomial Outbreak Caused by Multidrug-Resistant Pseudomonas aeruginosa Producing IMP-13 Metallo-β-Lactamase 124
Prevalence and sensitivity profile to 5 antifungalagents of yeast species causing onychomycosis and vaginitis 124
Utilizzo dei pannelli Microscan per valutare, in accordo con i breakpoint clinici EUCAST, la sensibilità antimicrobica di isolati Gram-negativi produttori di β-lattamasi. 124
DECLINE OF MATERNAL HAV ANTIBODIES IN NEONATAL COHORT. 124
Coesistenza di Klebsiella pneumoniae ed Escherichia coli kpc-3-produttori in una paziente in terapia intensiva. 122
Occurrence of extended spectrum β-lactamases, KPC-Type, and MCR-1.2-producing enterobacteriaceae from wells, river water, and wastewater treatment plants in Oltrepò Pavese area, Northern Italy 121
CARATTERIZZAZIONE DI STIPITI DI E. COLI PRODUTTORI DI ESßL ISOLATI DA EMOCOLTURE 119
Molecular epidemiology of VIM-1-producing Klebsiella pneumoniae in Italy 118
Prevalence of urinary colonization by extended spectrum-beta-lactamase Enterobacteriaceae among catheterised inpatients in Italian long term care facilities. 118
Emergenza di Escherichia coli MDR kpc-2 produttori in due ospedali italiani. 118
Emergence of Escherichia coli Sequence Type 131 (ST131) and ST3948 with KPC-2, KPC-3 and KPC-8 carbapenemases from a Long-Term Care and Rehabilitation Facility (LTCRF) in Northern Italy 118
ST405 NDM-5 Producing Escherichia coli in Northern Italy: The First Two Clinical Cases 117
Outbreak of multidrug-resistant Pseudomonas aeruginosa producing the metallo beta-lactamase IMP-13 in a general Intensive Care Unit in Southern Italy 114
Emergence of a VIM-1 MBL and CTX-M-15 ESbL-producing Klebsiella pneumoniae clone from acute and rehabilitation hospitals in Italy. 114
Recurrent vulvovaginal candidiasis: prevalence, antifungal susceptibility patterns and genotyping of different species 113
Nosocomial infections caused by pseudomonas aeruginosa with acquired blaVIM metallo-beta-lactamase genes in a hospital of Northern Italy 112
First report on K. pneumoniae strains producing both VIM and CTX-M transferable enzymes 112
Valutazione dell’attività in vitro di ceftaroline nei confronti di ceppi di Staphylococcus aureus MRSA e MSSA isolati in ambito ospedaliero ed ambulatoriale del nord Italia 112
PERSISTENZA DI ISOLATI DI ACINETOBACTER BAUMANNII MDR RESPONSABILI DI EPIDEMIE IN TRE OSPEDALI ITALIANI 111
Diffusione di due cloni di Escherichia coli kpc-produttori in reparti diversi di un ospedale per acuti del nord Italia. 111
Epidemia di Pseudomonas aeruginosa multiresistenti, produttori di metallo B-lattamasi IMP-13, in una unità di terapia intensiva dell'IRCCS "Casa sollievo della sofferenza" di San Giovanni Rotondo (FG) 110
Differences in biofilm formation and aggregative adherence between beta-lactam susceptible and beta-lactamases producing P. mirabilis clinical isolates. 109
Utilizzo della PFGE per lo studio di un'epidemia da S. aureus in un reparto di Patologia Neonatale 108
ENTEROBATTERI ESßL PRODUTTORI IN STRUTTURE DI LUNGODEGENZA (LTCF): PRIMO STUDIO ITALIANO DI PREVALENZA 107
DIFFUSIONE CLONALE DI PROTEUS MIRABILIS CMY-16 PRODUTTORE IN STRUTTURE DI LUNGODEGENZA RIABILITATIVE 107
Dissemination of CTX-M-type beta-lactamasesamong clinical isolates of E. coli from geriatriclong-term care and rehabilitation facilities innorthern Italy 107
Occurrence of micropollutants and enterobacteria in Ticino Valley: an insight of water contamination in an agricultural area with highly anthropogenic impact 105
DIFFUSIONE EPIDEMICA DI UN CEPPO MDR DI K. PNEUMONIAE CTX-M-15 PRODUTTORE IN UNA TERAPIA INTENSIVA NEONATALE 105
Usefulness of Microscan System panels with EUCAST clinical breakpoints to evaluate the antimicrobial susceptibility of ß-lactamase producing- Gram negative isolates. 105
Evaluation of the in vitro activity of ceftaroline and its potential against a collection of hospital-acquired methicillin-resistant Staphylococcus aureus and hospital-acquired methicillin-susceptible Staphylococcus aureus isolates recovered from various clinical samples 104
In vitro activity of ceftaroline against a collection of hospital-acquired MRSA (ha-MRSA) and ha-MSSA italian isolates. 104
Resistenza mediata da beta-lattamasi in isolati clinici di Acinetobacter baumannii MDR 103
Dissemination of acquired metallo-betalactamasesin Gram-negative pathogens: first Italian countrywide survey 102
Per-type beta-lactamase-producing Proteus Mirabilis strains causing otubreaks in a general hospital in northern Italy 101
Evaluation of aggregative adherence and biofilm formation in beta-lactamase producing Proteus mirabilis isolates from different clinical settings in Italy 101
Multifocal Detection of Multidrug-Resistant Pseudomonas aeruginosa Producing the PER-1 Extended-Spectrum β-Lactamase in Northern Italy 98
First Countrywide Survey of Acquired Metallo-β-Lactamases in Gram-Negative Pathogens in Italy 98
Negative correlation between biofilm formation and antibiotic sensitivity in clinical isolates of clonally related Acinetobacter baumannii 98
Outbreak of multidrug-resistant Acinetobacter baumannii producing the carbapenem hydrolysing beta-lactamase OXA-58 in a general intensive care unit in Southern Italy 97
Epidemiology of extended-spectrum beta-lactamase/metallo-beta-lactamase 97
Epidemiologia molecolare di isolati clinici di P. aeruginosa MDR produttori di metallo-ß-lattamasi di tipo VIM-1 in una struttura di neuroriabilitazione 96
Valutazione del test cromogeno b-lactatm per l’identificazione rapida di Enterobatteri resistenti alle cefalosporine ad ampio spettro. 96
Extended-Spectrum Beta-Lactamases (ESBLs) Producing Enterobacteriaceae in Long-Term Care Facilities (LTCFs): Results of the First Italian Nationwide Prevalence Study 95
Presenza di Escherichia coli ST131, ST3680, ST3681 KPC produttori in differenti strutture del nord Italia. 95
Prevalence and antifungal susceptibility patternsof yeasts from women with vulvovaginitis 95
Mechanisms of environmental persistence of multidrug resistant Acinetobacter baumannii isolates responsible for outbreaks in three Italian hospitals 94
Diffusione epidemica di E. coli produttori di ESBL di tipo CTX-M in ospedali geriatrici 93
PREVALENZA DI P. MIRABILIS ED E. COLI ESβL PRODUTTORI NELLE LUNGODEGENZE DELLA PROVINCIA DI LODI 93
Spread of CTX-M extended-spectrum beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolates in Italian long-term care facilities: results of the first nationwide prevalence study 92
Surveillance and molecular epidemiology of KPC-producing Klebsiella pneumoniae strains from an intensive care unit 92
VALUTAZIONE DI UN TERRENO COMMERCIALE PER LA RILEVAZIONE DEGLI ENTEROBATTERI ESßL PRODUTTORI 91
First detection of Escherichia coli and Klebsiella pneumoniae clinical isolates producing acquired beta-lactamases of the CMY-LAT lineage in Italy 88
Multiclonal Diffusion of Carbapenem-Resistant Acinetobacter Baumannii Producing OXA-Type Enzymes in Italian Hospitals 88
Epidemiologia molecolare di P. mirabilis produttori di ESBL in una struttura di lungodegenza riabilitativa geriatrica 88
KPC-2- and KPC-3- Producing Escherichia coli from Three Northern Italy Facilities: ST131 Dissemination and ST3681 Emergence. 87
Valutazione di due metodi commerciali per la diagnosi rapida di Mycobacterium tuberculosis complex in campioni clinici 83
Rapid Control of Two Outbreaks of Serratia marcescens in a Northern Italian Neonatal Intensive Care Unit. 83
Molecular epidemiology of ESβL producing P. mirabilis strains from a long-term care and rehabilitation facility in Italy 79
Usefulness of Microscan System panels with EUCAST clinical breakpoints to evaluate the antimicrobial susceptibility of beta-lactamase producing Gram-negative isolates 77
ENTEROBATTERI PRODUTTORI DI ß-LATTAMASI DI CLASSE C ACQUISITE: UN PROBLEMA DIAGNOSTICO EMERGENTE 76
Diffusione di Extended-Spectrum-ß-Lattamasi di tipo CTX-M in isolati clinici di E. coli provenienti da strutture di lungodegenza e riabilitazione geriatriche del Nord Italia 75
ß-LATTAMASI DI TIPO AMPC ACQUISITE IN PROTEUS MIRABILIS: UN FENOMENO IN AUMENTO NELLA PRATICA ASSISTENZIALE 75
Colonization of Residents and Staff of an Italian Long-Term Care Facility and an Adjacent Acute Care Hospital Geriatrics Unit by Multidrug-Resistant Bacteria 65
Molecular epidemiology and beta-lactamaseproduction of multidrug resistant Acinetobacterbaumannii clinical isolates from Italian hospitals 61
Resident OXA-51-like carbapenemases in Acinetobacter baumannii: a useful marker for genotyping? 59
Totale 11.013
Categoria #
all - tutte 42.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.112


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022462 0 0 0 16 8 33 9 24 30 13 76 253
2022/20231.640 164 133 16 132 187 187 0 108 657 12 28 16
2023/2024627 71 99 45 40 84 154 22 38 6 32 24 12
2024/20251.369 42 118 43 52 46 84 66 84 332 34 170 298
2025/20262.977 246 241 313 285 378 187 577 115 263 251 75 46
2026/2027769 61 145 182 381 0 0 0 0 0 0 0 0
Totale 11.013